Literature DB >> 15213246

Subcellular localization of fukutin and fukutin-related protein in muscle cells.

Hiroshi Matsumoto1, Satoru Noguchi, Kazuma Sugie, Megumu Ogawa, Kumiko Murayama, Yukiko K Hayashi, Ichizo Nishino.   

Abstract

Fukuyama-type congenital muscular dystrophy and congenital muscular dystrophy 1C are congenital muscular dystrophies that commonly display reduced levels of glycosylation of alpha-dystroglycan in skeletal muscle. The genes responsible for these disorders are fukutin and fukutin-related protein (FKRP), respectively. Both gene products are thought to be glycosyltransferases, but their functions have not been established. In this study, we determined their subcellular localizations in cultured skeletal myocytes. FKRP localizes in rough endoplasmic reticulum, while fukutin localizes in the cis-Golgi compartment. FKRP was also localized in rough endoplasmic reticulum in skeletal muscle biopsy sample. Our data suggest that fukutin and FKRP may be involved at different steps in O-mannosylglycan synthesis of alpha-dystroglycan, and FKRP is most likely involved in the initial step in this synthesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15213246     DOI: 10.1093/jb/mvh086

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  20 in total

1.  Probing the oligomeric state and interaction surfaces of Fukutin-I in dilauroylphosphatidylcholine bilayers.

Authors:  P Marius; Yuk Ming Leung; T J Piggot; S Khalid; P T F Williamson
Journal:  Eur Biophys J       Date:  2011-11-11       Impact factor: 1.733

2.  Mislocalization of fukutin protein by disease-causing missense mutations can be rescued with treatments directed at folding amelioration.

Authors:  Masaji Tachikawa; Motoi Kanagawa; Chih-Chieh Yu; Kazuhiro Kobayashi; Tatsushi Toda
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

3.  Biochemical and ultrastructural evidence of endoplasmic reticulum stress in LGMD2I.

Authors:  Chiara A Boito; Marina Fanin; Bruno F Gavassini; Giovanna Cenacchi; Corrado Angelini; Elena Pegoraro
Journal:  Virchows Arch       Date:  2007-10-20       Impact factor: 4.064

4.  A role of fukutin, a gene responsible for Fukuyama type congenital muscular dystrophy, in cancer cells: a possible role to suppress cell proliferation.

Authors:  Tomoko Yamamoto; Yoichiro Kato; Noriyuki Shibata; Tatsuo Sawada; Makiko Osawa; Makio Kobayashi
Journal:  Int J Exp Pathol       Date:  2008-10       Impact factor: 1.925

Review 5.  Mechanisms of disease: congenital muscular dystrophies-glycosylation takes center stage.

Authors:  Paul T Martin
Journal:  Nat Clin Pract Neurol       Date:  2006-04

6.  Direct Mapping of Additional Modifications on Phosphorylated O-glycans of α-Dystroglycan by Mass Spectrometry Analysis in Conjunction with Knocking Out of Causative Genes for Dystroglycanopathy.

Authors:  Hirokazu Yagi; Chu-Wei Kuo; Takayuki Obayashi; Satoshi Ninagawa; Kay-Hooi Khoo; Koichi Kato
Journal:  Mol Cell Proteomics       Date:  2016-09-06       Impact factor: 5.911

7.  Post-Natal knockdown of fukutin-related protein expression in muscle by long-termRNA interference induces dystrophic pathology [corrected].

Authors:  Chi-Hsien Wang; Yiumo Michael Chan; Ru-Hang Tang; Bin Xiao; Peijuan Lu; Elizabeth Keramaris-Vrantsis; Hui Zheng; Chunping Qiao; Jiangang Jiang; Juan Li; Hsin-I Ma; Qilong Lu; Xiao Xiao
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

Review 8.  The dystroglycanopathies: the new disorders of O-linked glycosylation.

Authors:  Paul T Martin
Journal:  Semin Pediatr Neurol       Date:  2005-09       Impact factor: 1.636

9.  Expression and purification of the transmembrane domain of Fukutin-I for biophysical studies.

Authors:  P Marius; J N Wright; I S Findlow; P T F Williamson
Journal:  Protein Expr Purif       Date:  2010-02-01       Impact factor: 1.650

Review 10.  Muscular dystrophies due to glycosylation defects.

Authors:  Francesco Muntoni; Silvia Torelli; Martin Brockington
Journal:  Neurotherapeutics       Date:  2008-10       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.